SEKISUI Diagnostics

SEKISUI Diagnostics is a leading medical diagnostics company headquartered in Burlington, MA, with a 40-year track record of commitment to improving patient lives through innovative diagnostics for physicians and laboratories. The company has a strong focus on diabetes, infectious disease, coagulation, diagnostic enzymes, and automated systems. It holds a prominent position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.

With a workforce spanning six sites across four countries and as a sister company to SEKISUI Medical in Japan, the company has a global presence with R&D and Manufacturing facilities on three continents. They are responsible for the development, manufacturing, and supply of billions of tests annually to the global healthcare market through commercial networks and partners.

Their product lines include clinical chemistry reagents, coagulation reagents, point-of-care rapid tests and immunoassay systems, enzymes, and specialty biochemicals. Although no details about their last investment are available currently, the company operates in the Healthcare and Manufacturing industries. SEKISUI Diagnostics continues to uphold its mission with the slogan "Because Every Result Matters," showcasing its dedication to improving patient outcomes.